Study of CM529D1 in Participants With Advanced Solid Tumors

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This is interventional study to evaluate the safety and tolerability, pharmacokinetics, immunogenicity, and preliminary efficacy of CM529D1 in participants with advanced solid tumors.
Epistemonikos ID: 792c17d84c077b74ce3f80d6ca904c15e8d526c9
First added on: Oct 24, 2026